559 related articles for article (PubMed ID: 31366408)
1. Rural access to MAT in Pennsylvania (RAMP): a hybrid implementation study protocol for medication assisted treatment adoption among rural primary care providers.
Cochran G; Cole ES; Warwick J; Donohue JM; Gordon AJ; Gellad WF; Bear T; Kelley D; DiDomenico E; Pringle J
Addict Sci Clin Pract; 2019 Aug; 14(1):25. PubMed ID: 31366408
[TBL] [Abstract][Full Text] [Related]
2. The Role of Primary Care in Improving Access to Medication-Assisted Treatment for Rural Medicaid Enrollees with Opioid Use Disorder.
Cole ES; DiDomenico E; Cochran G; Gordon AJ; Gellad WF; Pringle J; Warwick J; Chang CH; Kim JY; Kmiec J; Kelley D; Donohue JM
J Gen Intern Med; 2019 Jun; 34(6):936-943. PubMed ID: 30887440
[TBL] [Abstract][Full Text] [Related]
3. Strategies to recruit rural primary care providers to implement a medication for opioid use disorder (MOUD) focused integrated care model.
Cloutier RM; Cole ES; McDonough BL; Lomauro DA; Miller JP; Talbert AL; Bear TM; Bridges NC; Foulds AL; Taber R; Gordon AJ; Cochran GT; Kmiec J; Donohue JM; Kelley D; DiDomenico E; Adair D; Pringle JL
Implement Res Pract; 2023; 4():26334895231152808. PubMed ID: 37091535
[TBL] [Abstract][Full Text] [Related]
4. Addressing opioid use disorder among rural pregnant and postpartum women: a study protocol.
Bryan MA; Smid MC; Cheng M; Fortenberry KT; Kenney A; Muniyappa B; Pendergrass D; Gordon AJ; Cochran G
Addict Sci Clin Pract; 2020 Oct; 15(1):33. PubMed ID: 33129355
[TBL] [Abstract][Full Text] [Related]
5. Experiences of three states implementing the Medicaid health home model to address opioid use disorder-Case studies in Maryland, Rhode Island, and Vermont.
Clemans-Cope L; Wishner JB; Allen EH; Lallemand N; Epstein M; Spillman BC
J Subst Abuse Treat; 2017 Dec; 83():27-35. PubMed ID: 29129193
[TBL] [Abstract][Full Text] [Related]
6. Developing a clinical decision support for opioid use disorders: a NIDA center for the clinical trials network working group report.
Bart GB; Saxon A; Fiellin DA; McNeely J; Muench JP; Shanahan CW; Huntley K; Gore-Langton RE
Addict Sci Clin Pract; 2020 Jan; 15(1):4. PubMed ID: 31948487
[TBL] [Abstract][Full Text] [Related]
7. The Washington State Hub and Spoke Model to increase access to medication treatment for opioid use disorders.
Reif S; Brolin MF; Stewart MT; Fuchs TJ; Speaker E; Mazel SB
J Subst Abuse Treat; 2020 Jan; 108():33-39. PubMed ID: 31358328
[TBL] [Abstract][Full Text] [Related]
8. Multi-model implementation of evidence-based care in the treatment of opioid use disorder in Pennsylvania.
Kawasaki S; Francis E; Mills S; Buchberger G; Hogentogler R; Kraschnewski J
J Subst Abuse Treat; 2019 Nov; 106():58-64. PubMed ID: 31540612
[TBL] [Abstract][Full Text] [Related]
9. Test of a workforce development intervention to expand opioid use disorder treatment pharmacotherapy prescribers: protocol for a cluster randomized trial.
Molfenter T; Knudsen HK; Brown R; Jacobson N; Horst J; Van Etten M; Kim JS; Haram E; Collier E; Starr S; Toy A; Madden L
Implement Sci; 2017 Nov; 12(1):135. PubMed ID: 29141653
[TBL] [Abstract][Full Text] [Related]
10. Age related medication for addiction treatment (MAT) use for opioid use disorder among Medicaid-insured patients in New York.
Neighbors CJ; Choi S; Healy S; Yerneni R; Sun T; Shapoval L
Subst Abuse Treat Prev Policy; 2019 Jun; 14(1):28. PubMed ID: 31238952
[TBL] [Abstract][Full Text] [Related]
11. Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH).
D'Onofrio G; Edelman EJ; Hawk KF; Pantalon MV; Chawarski MC; Owens PH; Martel SH; VanVeldhuisen P; Oden N; Murphy SM; Huntley K; O'Connor PG; Fiellin DA
Implement Sci; 2019 May; 14(1):48. PubMed ID: 31064390
[TBL] [Abstract][Full Text] [Related]
12. Response to coronavirus 2019 in Veterans Health Administration facilities participating in an implementation initiative to enhance access to medication for opioid use disorder.
Gustavson AM; Gordon AJ; Kenny ME; McHenry H; Gronek J; Ackland PE; Hagedorn HJ
Subst Abus; 2020; 41(4):413-418. PubMed ID: 32936695
[TBL] [Abstract][Full Text] [Related]
13. Barriers and perceived usefulness of an ECHO intervention for office-based buprenorphine treatment for opioid use disorder in North Carolina: A qualitative study.
Shea CM; Gertner AK; Green SL
Subst Abus; 2021; 42(1):54-64. PubMed ID: 31809679
[TBL] [Abstract][Full Text] [Related]
14. Review of medication-assisted treatment for opioid use disorder.
Ghanem N; Dromgoole D; Hussein A; Jermyn RT
J Osteopath Med; 2022 Mar; 122(7):367-374. PubMed ID: 35285220
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of US Counties With High Opioid Overdose Mortality and Low Capacity to Deliver Medications for Opioid Use Disorder.
Haffajee RL; Lin LA; Bohnert ASB; Goldstick JE
JAMA Netw Open; 2019 Jun; 2(6):e196373. PubMed ID: 31251376
[TBL] [Abstract][Full Text] [Related]
16. PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment.
Campbell CI; Saxon AJ; Boudreau DM; Wartko PD; Bobb JF; Lee AK; Matthews AG; McCormack J; Liu DS; Addis M; Altschuler A; Samet JH; LaBelle CT; Arnsten J; Caldeiro RM; Borst DT; Stotts AL; Braciszewski JM; Szapocznik J; Bart G; Schwartz RP; McNeely J; Liebschutz JM; Tsui JI; Merrill JO; Glass JE; Lapham GT; Murphy SM; Weinstein ZM; Yarborough BJH; Bradley KA
Addict Sci Clin Pract; 2021 Jan; 16(1):9. PubMed ID: 33517894
[TBL] [Abstract][Full Text] [Related]
17. Predictors of Medication Utilization for Opioid Use Disorder Among Medicaid-Insured HIV Patients in New York.
Choi S; Yerneni R; Healy S; Goyal M; Neighbors CJ
Am J Addict; 2020 Mar; 29(2):151-154. PubMed ID: 31951083
[TBL] [Abstract][Full Text] [Related]
18. Advancing pharmacological treatments for opioid use disorder (ADaPT-OUD): protocol for testing a novel strategy to improve implementation of medication-assisted treatment for veterans with opioid use disorders in low-performing facilities.
Hagedorn H; Kenny M; Gordon AJ; Ackland PE; Noorbaloochi S; Yu W; Harris AHS
Addict Sci Clin Pract; 2018 Dec; 13(1):25. PubMed ID: 30545409
[TBL] [Abstract][Full Text] [Related]
19. A statewide quality improvement (QI) initiative for better health outcomes and family stability among pregnant women with opioid use disorder (OUD) and their infants.
Crane D; Marcotte M; Applegate M; Massatti R; Hurst M; Menegay M; Mauk R; Williams S
J Subst Abuse Treat; 2019 Jul; 102():53-59. PubMed ID: 31202289
[TBL] [Abstract][Full Text] [Related]
20. A review of a national training initiative to increase provider use of MAT to address the opioid epidemic.
Levin FR; Bisaga A; Sullivan MA; Williams AR; Cates-Wessel K
Am J Addict; 2016 Dec; 25(8):603-609. PubMed ID: 28051841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
